ProfileGDS4718 / 208873_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 96% 98% 95% 97% 95% 98% 96% 97% 97% 97% 96% 97% 94% 96% 97% 98% 96% 97% 95% 96% 97% 97% 97% 97% 96% 98% 98% 97% 98% 95% 96% 96% 96% 98% 97% 98% 97% 97% 98% 96% 97% 97% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.468695
GSM549102patient 115, normal, homogenized [OPG study]10.535396
GSM549104patient 119, normal, homogenized [OPG study]11.613498
GSM549108patient 138, normal, homogenized [OPG study]10.298495
GSM549119patient 077, normal, homogenized [OPG study]11.145697
GSM549133patient 032, cancer, homogenized [OPG study]10.341495
GSM549139patient 042, cancer, homogenized [OPG study]11.145798
GSM549099patient 107, normal, homogenized [OPG study]10.615696
GSM549109patient 139, normal, homogenized [OPG study]11.139197
GSM549110patient 046, normal, homogenized [OPG study]11.021197
GSM549114patient 063, normal, homogenized [OPG study]11.183897
GSM549122patient 082, normal, homogenized [OPG study]10.778896
GSM549134patient 033, cancer, homogenized [OPG study]10.713297
GSM549136patient 036, cancer, homogenized [OPG study]10.028694
GSM549140patient 044, cancer, homogenized [OPG study]10.656296
GSM549111patient 047, normal, homogenized [OPG study]11.153897
GSM549113patient 057, normal, homogenized [OPG study]11.413798
GSM549132patient 031, cancer, homogenized [OPG study]10.286696
GSM549137patient 038, cancer, homogenized [OPG study]10.910297
GSM549142patient 047, cancer, homogenized [OPG study]9.7105495
GSM549100patient 110, normal, homogenized [OPG study]10.722496
GSM549107patient 135, normal, homogenized [OPG study]10.864497
GSM549115patient 068, normal, homogenized [OPG study]11.110897
GSM549116patient 072, normal, homogenized [OPG study]10.925797
GSM549120patient 078, normal, homogenized [OPG study]10.877297
GSM549131patient 030, cancer, homogenized [OPG study]10.4796
GSM549118patient 074, normal, homogenized [OPG study]11.50298
GSM549129patient 027, cancer, homogenized [OPG study]10.969998
GSM549123patient 088, normal, homogenized [OPG study]10.955597
GSM549124patient 006, cancer, homogenized [OPG study]11.40998
GSM549126patient 015, cancer, homogenized [OPG study]10.063495
GSM549128patient 025, cancer, homogenized [OPG study]10.588696
GSM549103patient 117, normal, homogenized [OPG study]10.506296
GSM549117patient 073, normal, homogenized [OPG study]10.661396
GSM549138patient 041, cancer, homogenized [OPG study]11.16598
GSM549141patient 045, cancer, homogenized [OPG study]11.04797
GSM549130patient 028, cancer, homogenized [OPG study]11.179698
GSM549101patient 111, normal, homogenized [OPG study]10.867297
GSM549105patient 128, normal, homogenized [OPG study]10.755897
GSM549106patient 134, normal, homogenized [OPG study]11.747898
GSM549112patient 048, normal, homogenized [OPG study]10.800896
GSM549125patient 011, cancer, homogenized [OPG study]10.816197
GSM549127patient 024, cancer, homogenized [OPG study]10.665697
GSM549135patient 035, cancer, homogenized [OPG study]9.6394292